The CardioFocus HeartLight Excalibur Balloon X3 ablation system allows direct visualization of the laser ablation procedure, helping reduce use of X-ray angiography and reducing procedure time. FDA clears, approved, the HeartLight X3 Laser Ablation System to Treat Atrial Fibrillation.
News | EP Lab
FDA Clears HeartLight X3 Laser Ablation System to Treat Atrial Fibrillation

May 12, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the next-generation CardioFocus Inc. HeartLight ...

Home May 12, 2020
Home
AMID's high definition blood flow tracking software for echocardiography.
News | Advanced Visualization
Medis Acquires Cardiovascular Advanced Imaging Vendor AMID

May 12, 2020 — Medis acquired Advanced Medical Imaging Development S.r.l. (AMID), a developer and supplier specialized ...

Home May 12, 2020
Home
American Society for Preventive Cardiology (ASPC) Offers Survey to Aid Healthy Lifestyle During COVID-19
News | Cardiac Diagnostics
American Society for Preventive Cardiology Offers Survey to Aid Healthy Lifestyle During COVID-19

May 11, 2020 — The American Society for Preventive Cardiology (ASPC) is collaborating with Intervent International to ...

Home May 11, 2020
Home
New Multimodality Cardiac Imaging Guidelines for Competitive Athletes Created. ASE SCCT and SCMR recommendations for imaging, screening atheletes.
News | Cardiac Imaging
New Multimodality Cardiac Imaging Guidelines for Competitive Athletes Created

May 11, 2020 – Competitive athletes are a rapidly growing population worldwide. Habitual vigorous exercise, a defining ...

Home May 11, 2020
Home
​​​​​​​American College of Cardiology, ACC, NCDR Chest Pain MI and CathPCI Registries Collect COVID-19 Data
News | Coronavirus (COVID-19)
​​​​​​​American College of Cardiology Registries Collect COVID-19 Data

May 11, 2020 — The American College of Cardiology (ACC) will begin collecting COVID-19 (SARS-CoV-2) data through the ...

Home May 11, 2020
Home
The global, prospective, non-randomized UNTOUCHED study evaluated the safety and efficacy of the Boston Scientific Emblem S-ICD System – the only approved implantable defibrillator without wires touching the heart – for primary prevention of sudden cardiac death specifically in patients with a left ventricular ejection fraction (LVEF) ≤35 percent, the most common population to be indicated for ICD therapy. #Heartrhythm2020 #HRS20 #HRS2020
News | Implantable Cardioverter Defibrillator (ICD)
UNTOUCHED Trial Data Underscores Safety And Efficacy Of Boston Scientific S-ICD System

May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System ...

Home May 08, 2020
Home
The Swiss-AF study shows High Incidence Of Silent Brain Infarcts Found in Anticoagulated Atrial Fibrillation Patients. #Heartrhythm2020 #HRS20 #HRS2020
News | Atrial Fibrillation
High Incidence Of Silent Brain Infarcts Found in Anticoagulated Atrial Fibrillation Patients

May 8, 2020 – A new clinical study found that patients with atrial fibrillation (AF) experienced a high incidence of ...

Home May 08, 2020
Home
PINNACLE FLX Study of New Watchman FLX LAA Occluder Meets Safety and Efficacy Endpoints. #Heartrhythm2020 #HRS20 #HRS2020
News | Atrial Fibrillation
PINNACLE FLX Study of New Watchman FLX LAA Occluder Meets Safety and Efficacy Endpoints 

May 8, 2020 — Positive 12-month results were announced today from the PINNACLE FLX clinical trial assessing the safety ...

Home May 08, 2020
Home
The SERF VT EFS is a groundbreaking, single-arm observational study designed to evaluate the safety and effectiveness of the Thermedical Durablate catheter to treat VT. #HRS20 #HRS2020 #heartrhythm2020
News
Saline Enhanced Radiofrequency Ablation May be an Effective Method to Treat Ventricular Tachycardia

May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SERF) ...

Home May 08, 2020
Home
The first-in-human results show positive results for Medtronic's pulsed field ablation in safety and efficiency. #Heartrhythm2020 #HRS2020 #HRS20
News | Atrial Fibrillation
Pulsed AF Trial Shows Pulsed Field Ablation May be Safer Than Traditional RF Ablations

May 8, 2020 — New clinical trial reveals the first-in-human results for paroxysmal or persistent atrial fibrillation (AF ...

Home May 08, 2020
Home
The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.
Feature | Implantable Cardioverter Defibrillator (ICD)
Head-to-head Comparison Shows Subcutaneous ICDs Safer Than Transvenous Defibrillators 

May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable ...

Home May 08, 2020
Home
The Affera Inc. pulsed field (PF) energy radiofrequency ablation system. First-in-human trial shows new point-by-point approach provides increased flexibility and efficiency for physicians treating arrhythmia patients. #HRS #HRS2020 #HRS20 #heartrhythm20
Feature
Pulsed Field Ablation Successfully Treats Atrial Fibrillation

May 8, 2020 — A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or ...

Home May 08, 2020
Home
Necklace Patient Monitor Detects Abnormal Heart Rhythm. An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC). This wearable necklace ECG monitor provides a new and easy method for detecting an abnormal heart rhythm called atrial fibrillation and is accurate, according to a new study from the University of Eastern Finland.
News | Wearables
Necklace Monitors ECG and Detects Abnormal Heart Rhythms

May 2020 — An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on ...

Home May 08, 2020
Home
Videos | Coronavirus (COVID-19)
VIDEO: CT and POCUS Emerge As Frontline Cardiac Imaging Modalities in COVID-19 Era

Interview with Geoffrey Rose, M.D., president of Sanger Heart and Vascular Institute with Atrium Health, in Charlotte ...

Home May 07, 2020
Home
FDA Clears Dapagliflozin to Treat Heart Failure With Reduced Ejection Fraction. This was based on data from the DAPA-HF Trial. John McMurray, M.D., presenting the DAPA-HF Trial at AHA 2019 last November. It was part of the late-breaking presentations in the "Outside the Box: New Approaches to CVD Risk Reduction" session. Photo by AHA/Phil McCarten
Feature
FDA Clears Dapagliflozin to Treat Heart Failure With Reduced Ejection Fraction

May 6, 2020 — The U.S. Food and Drug Administration approved AstraZeneca’s dapagliflozin (Farxiga) oral tablets for ...

Home May 06, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now